{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T05:05:53Z","timestamp":1700370353652},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:00:00Z","timestamp":1695686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Plasmacytoma, a localized tumor of monoclonal plasma cells without any clinical, radiological or physical evidence of plasma cell neoplasm (PCN), is a rare entity that accounts for 1% of PCN. Immunoglobulin M (IgM) extramedullary plasmacytoma of mediastinal region has never been reported and is a diagnostic challenge considering other differential diagnoses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>We present the case of a 51-year-old African-American female with progressively increasing cough, dyspnea, and dysphagia for 6\u00a0months with a computed tomography (CT) scan revealing a subcarinal mass. The histopathological analysis of the mass reveals a diagnosis of lymphoma with plasma cell differentiation, with a differential of lymphoplasmacytic lymphoma and plasma cell neoplasm. The lymphoma panel via next-generation sequencing (NGS) and a myeloma-targeted fluorescent in situ hybridization (FISH) panel confirmed the diagnosis of IgM extramedullary plasmacytoma, an entity of rare occurrence. Treatment with radiation led to complete regression of the plasmacytoma with normal blood work-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This report describes the challenges of diagnosing IgM extramedullary plasmactyoma. Our case report highlights the importance of cytogenetics and NGS in establishing a correct diagnosis that indeed has prognostic and therapeutic implications.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-023-04082-x","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T00:01:52Z","timestamp":1695686512000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hematological entities with plasmacytic differentiation: a case report\u00a0"],"prefix":"10.1186","volume":"17","author":[{"given":"Arati","family":"Inamdar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siddharth","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,26]]},"reference":[{"key":"4082_CR1","volume-title":"World Health Organization classification of tumours of haematopoietic and lymphoid tissues, revised","author":"SH Swerdlow","year":"2017","unstructured":"Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. World Health Organization classification of tumours of haematopoietic and lymphoid tissues, revised. 4th ed. Lyon: IARC; 2017.","edition":"4"},{"key":"4082_CR2","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1365-2141.2008.07421.x","volume":"144","author":"GM Dores","year":"2009","unstructured":"Dores GM, Landgren O, McGlynn KA, Curtis RE, Linet MS, Devesa SS. Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992\u20132004. Br J Haematol. 2009;144:86\u201394.","journal-title":"Br J Haematol"},{"key":"4082_CR3","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jaci.2013.01.046","volume":"131","author":"K Pieper","year":"2013","unstructured":"Pieper K, Grimbacher B, Eibel H. B-cell biology and development. J Allergy Clin Immunol. 2013;131:959\u201371.","journal-title":"J Allergy Clin Immunol"},{"key":"4082_CR4","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nri1572","volume":"5","author":"M Shapiro-Shelef","year":"2005","unstructured":"Shapiro-Shelef M, Calame K. Regulation of plasma-cell development. Nat Rev Immunol. 2005;5:230\u201342.","journal-title":"Nat Rev Immunol"},{"key":"4082_CR5","unstructured":"Fagiolo E, Tosato G. IgM plasmacytoma. Report of a case and review of the literature. Haematologia (Budap). 1978\u20131979;12:221\u20139."},{"key":"4082_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/00000372-198100310-00011","volume":"3","author":"NA Swanson","year":"1981","unstructured":"Swanson NA, Keren DF, Headington JT. Extramedullary IgM plasmacytoma presenting in skin. Am J Dermatopathol. 1981;3:79\u201383.","journal-title":"Am J Dermatopathol"},{"key":"4082_CR7","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/0090-4295(92)90471-8","volume":"40","author":"K Tadashi","year":"1992","unstructured":"Tadashi K, Kazuhiro Y, Hideki I, Kanhin T, Takeru H. IgM-producing renal plasmacytoma. Urology. 1992;40:484\u20138.","journal-title":"Urology"},{"key":"4082_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1002\/1097-0142(1984)54:4<638::AID-CNCR2820540409>3.0.CO;2-A","volume":"4","author":"N Funakoshi","year":"1984","unstructured":"Funakoshi N, Kanoh T, Kobayashi Y, Miyake T, Uchino H, Ochi K. IgM-producing gastric plasmacytoma. Cancer. 1984;4:638\u201343.","journal-title":"Cancer"},{"key":"4082_CR9","first-page":"655","volume":"28","author":"HF Chen","year":"2007","unstructured":"Chen HF, Fu WJ, Wang DX, Yuan ZG, Chen YB, Hou J. Clinical features of multiple myeloma patients with extramedullary disease: a report of 40 cases from a single center. Zhonghua Xue Ye Xue Za Zhi. 2007;28:655\u20138.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"4082_CR10","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/1757-1626-1-207","volume":"1","author":"I Tahan","year":"2008","unstructured":"Tahan I, Seale J, Edwards D. IgM multiple myeloma presenting with spinal cord compression caused by a plasmacytoma: a case report. Cases J. 2008;1:207.","journal-title":"Cases J"},{"issue":"92","key":"4082_CR11","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/ajh.24753","volume":"2017","author":"JJ Castillo","year":"2017","unstructured":"Castillo JJ, Jurczyszyn A, Brozova L, Crusoe E, Czepiel J, Davila J, Dispenzieri A, Eveillard M, Fiala MA, Ghobrial IM, Gozzetti A. IgM myeloma: a multicenter retrospective study of 134 patients. Am J Hematol. 2017;2017(92):746\u201351.","journal-title":"Am J Hematol"},{"key":"4082_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/ajcp\/aqab095","volume":"157","author":"H Lu","year":"2022","unstructured":"Lu H, Durkin L, Zhao X, Nakashima MO. IgM plasma cell myeloma: clinicopathologic features including evaluation for MYD88 and CXCR4 mutations. Am J Clin Pathol. 2022;157:47\u201353.","journal-title":"Am J Clin Pathol"},{"key":"4082_CR13","doi-asserted-by":"publisher","first-page":"580","DOI":"10.5858\/arpa.2012-0034-RS","volume":"137","author":"N Naderi","year":"2013","unstructured":"Naderi N, Yang DT. Lymphoplasmacytic lymphoma and Waldenstr\u00f6m macroglobulinemia. Arch Pathol Lab Med. 2013;137:580\u20135.","journal-title":"Arch Pathol Lab Med"},{"key":"4082_CR14","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/bjh.13361","volume":"169","author":"J Schmidt","year":"2015","unstructured":"Schmidt J, Federmann B, Schindler N, Steinhilber J, Bonzheim I, Fend F, Quintanilla-Martinez L. MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity. Br J Haematol. 2015;169:795\u2013803.","journal-title":"Br J Haematol"},{"key":"4082_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00428-015-1858-9","volume":"468","author":"SH Swerdow","year":"2016","unstructured":"Swerdow SH, Kuzu I, Dogan A, Dirnhofer S, Chan JK, Sander B, Ott G, Xerri L, Quintanilla-Martinez L, Campo E. The many faces of small B cell lymphomas with plasmacytic differentiation and the contribution of MYD88 testing. Virchows Arch. 2016;468:259\u201375.","journal-title":"Virchows Arch"},{"key":"4082_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21037\/aol-20-28","volume":"5","author":"JR Cerhan","year":"2021","unstructured":"Cerhan JR, Habermann TM. Epidemiology of marginal zone lymphoma. Ann Lymphoma. 2021;5:1.","journal-title":"Ann Lymphoma"},{"key":"4082_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1309\/AJCP63OGXHXCSKSC","volume":"136","author":"TJ Molina","year":"2011","unstructured":"Molina TJ, Lin P, Swerdlow SH, Cook J. Marginal zone lymphomas with plasmacytic differentiation and related disorders. Am J Clin Path. 2011;136:211\u201325.","journal-title":"Am J Clin Path"},{"key":"4082_CR18","first-page":"206","volume":"36","author":"JP Alderuccio","year":"2022","unstructured":"Alderuccio JP, Kahl BS. Current treatments in marginal zone lymphoma. Oncology (Williston Park). 2022;36:206\u201315.","journal-title":"Oncology (Williston Park)"},{"key":"4082_CR19","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41571-018-0018-y","volume":"15","author":"SK Kumar","year":"2018","unstructured":"Kumar SK, Rajkumar SV. The multiple myelomas\u2014current concepts in cytogenetic classification and therapy. Nat Rev Clin Oncol. 2018;15:409\u201321.","journal-title":"Nat Rev Clin Oncol"},{"key":"4082_CR20","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13045-017-0549-1","volume":"11","author":"J Caers","year":"2018","unstructured":"Caers J, Paiva B, Zamagni E, Leleu X, Blad\u00e9 J, Kristinsson SY, Touzeau C, Abildgaard N, Terpos E, Heusschen R, Ocio E, Delforge M, Sezer O, Beksac M, Ludwig H, Merlini G, Moreau P, Zweegman S, Engelhardt M, Rosi\u00f1ol L. Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel. J Hematol Oncol. 2018;11:10.","journal-title":"J Hematol Oncol"},{"key":"4082_CR21","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1097\/PAS.0000000000000411","volume":"39","author":"A Martinez-Lopez","year":"2015","unstructured":"Martinez-Lopez A, Curiel-Olmo S, Mollejo M, Cereceda L, Martinez N, Montes-Moreno S, Almaraz C, Revert JB, Piris MA. MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma. Am J Surg Pathol. 2015;39:644\u20135.","journal-title":"Am J Surg Pathol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04082-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-04082-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04082-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T03:27:35Z","timestamp":1700364455000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-04082-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,26]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4082"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-04082-x","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,26]]},"assertion":[{"value":"25 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"429"}}